Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
PLoS One ; 10(11): e0142928, 2015.
Article in English | MEDLINE | ID: mdl-26606169

ABSTRACT

Apoptosis can be triggered in two different ways, through the intrinsic or the extrinsic pathway. The intrinsic pathway is mediated by the mitochondria via the release of cytochrome C while the extrinsic pathway is prompted by death receptor signals and bypasses the mitochondria. These two pathways are closely related to cell proliferation and survival signaling cascades, which thereby constitute possible targets for cancer therapy. In previous studies we introduced two plant derived isomeric flavonoids, flavone A and flavone B which induce apoptosis in highly tumorigenic cancer cells of the breast, colon, pancreas, and the prostate. Flavone A displayed potent cytotoxic activity against more differentiated carcinomas of the colon (CaCo-2) and the pancreas (Panc28), whereas flavone B cytotoxic action is observed on poorly differentiated carcinomas of the colon (HCT 116) and pancreas (MIA PaCa). Apoptosis is induced by flavone A in better differentiated colon cancer CaCo-2 and pancreatic cancer Panc 28 cells via the intrinsic pathway by the inhibition of the activated forms of extracellular signal-regulated kinase (ERK) and pS6, and subsequent loss of phosphorylation of Bcl-2 associated death promoter (BAD) protein, while apoptosis is triggered by flavone B in poorly differentiated colon cancer HCT 116 and MIA PaCa pancreatic cancer cells through the extrinsic pathway with the concomitant upregulation of the phosphorylated forms of ERK and c-JUN at serine 73. These changes in protein levels ultimately lead to activation of apoptosis, without the involvement of AKT.


Subject(s)
Cell Differentiation/drug effects , Flavones/pharmacology , Apoptosis/drug effects , Caspase 10/metabolism , Caspase 8/metabolism , Caspase 9/metabolism , Cell Cycle/drug effects , Cell Line, Tumor , Cell Proliferation/drug effects , Cell Survival/drug effects , Extracellular Signal-Regulated MAP Kinases/metabolism , Flavones/chemistry , Flavones/isolation & purification , Humans , Phosphorylation , Plant Extracts/chemistry , Plant Extracts/pharmacology , Ribosomal Protein S6 Kinases/metabolism , Signal Transduction/drug effects , bcl-Associated Death Protein/metabolism
2.
ChemSusChem ; 4(4): 514-8, 2011 Apr 18.
Article in English | MEDLINE | ID: mdl-21438156

ABSTRACT

Covalent coupling of Ru(II) light absorbers to a Rh(III) electron collecting site through polyazine bridging ligands affords photocatalytic production of H(2) in the presence of visible light and a sacrificial electron donor. A robust photocatalytic system displaying a high turnover of the photocatalyst has been developed using the photoinitiated electron collector [{(bpy)(2)Ru(dpp)}(2)RhBr(2)](5+) (bpy=2,2'-bipyridine; dpp=2,3-bis(2-pyridyl)pyrazine) and N,N-dimethylaniline in DMF/H(2)O. Studies have shown that increased [DMA], the headspace volume, and the use of DMF solvent improves the systems performance and stability providing mechanistic insight into the deactivation routes of the photocatalytic system. Photolysis of the system at 460 nm generates 20 mL of H(2) in 19.5 h with a maximum Φ=0.023 based on H(2) produced and an overall Φ=0.014 and 280 turnovers of the photocatalyst. The photocatalytic system also displays long-term photostability with 30 mL of H(2) generated and 420 turnovers in 50 h under the same conditions. Prolonged photolysis provides 820 mol H(2) per mole of catalyst.


Subject(s)
Hydrogen/chemistry , Photochemical Processes , Rhodium/chemistry , Ruthenium/chemistry , Water/chemistry , Aniline Compounds/chemistry , Catalysis , Electrons , Organometallic Compounds/chemistry , Oxidation-Reduction , Solvents/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL